Bringing a wealth of knowledge to the table.
We provide specialist legal advice to foreign clients acquiring, managing or divesting Australian investments. We have expert knowledge of Australia’s regulatory framework, and a wealth of experience with foreign investment proposals across a wide range of industry sectors including energy and resources, real estate, infrastructure, manufacturing, agribusiness and financial services.
We are privileged to be Australian counsel to leading overseas law firms and multinational clients on their Australian transactions and trading activities, as well the management of disputes arising in Australia. Regardless of time zones, our partners and lawyers are available to meet your requirements.
We maintain non-exclusive relationships with law firms throughout the world. We independently represent referrer firms looking for high quality and dependable legal representation in Australia. We work closely with major foreign law firms to meet the needs of multinational corporations operating in Australia, as well as Australian enterprises with international operations.
Many of our partners have experience in major US or English law firms and are dual qualified in the US, UK or Hong Kong. We are therefore familiar with the expectations and conventions of major law firms operating in the US, Asian and European commercial and financial markets.
With its relative economic stability, transparent legal and regulatory system, highly skilled workforce, natural resources and close proximity to Asia-Pacific markets, Australia has much to offer foreign investors.
Whether assisting with applications to the Foreign Investment Review Board or the other areas of law applicable to foreign investment including tax, corporate and financial services regulation, we are familiar with the needs of Australia’s foreign investors and their counsel.
This week marks a significant development in Australia’s privacy law reform process, which is likely to result in some changes becoming law before the next federal election.
The European Commission recently fined a large global pharmaceutical company €462.6 million for abusing its dominant position to lessen competition in the market for the supply of Copaxone...
The past year has undoubtedly been challenging for companies in the lithium, rare earth and critical minerals sectors. To provide some context, lithium carbonate, lithium hydroxide and spodumene...
Recent cases have highlighted whether an ASX-listed entity must make a market disclosure to the ASX if it receives a confidential compulsory investigation notice under section 155 of the...